MX2010001841A - Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas. - Google Patents

Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas.

Info

Publication number
MX2010001841A
MX2010001841A MX2010001841A MX2010001841A MX2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A
Authority
MX
Mexico
Prior art keywords
endophthalmitis
compositions
methods
modulating
fluoroquinolones
Prior art date
Application number
MX2010001841A
Other languages
English (en)
Inventor
Keith Wayne Ward
Jinzhong Zhang
Matthew Scott Jonasse
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of MX2010001841A publication Critical patent/MX2010001841A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Las composiciones para modular la endoftalmitis comprenden una fluoroquinolona que tiene una de las fórmulas l-VIII. Los métodos para modular la endoftalmitis comprenden administrar estas composiciones a un sujeto necesitado de las mismas. Las composiciones y métodos son adecuados para modular la endoftalmitis pos-operativa, endoftalmitis postraumática, endoftalmitis no infecciosa, panoftalmitis, endoftalmitis hematogénica y combinaciones de las mismas.
MX2010001841A 2007-08-21 2008-08-08 Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas. MX2010001841A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95700507P 2007-08-21 2007-08-21
PCT/US2008/072552 WO2009026009A1 (en) 2007-08-21 2008-08-08 Compositions and methods for modulating endophthalmitis using fluoroquinolones

Publications (1)

Publication Number Publication Date
MX2010001841A true MX2010001841A (es) 2010-03-10

Family

ID=39886006

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001841A MX2010001841A (es) 2007-08-21 2008-08-08 Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas.

Country Status (13)

Country Link
US (1) US20090054406A1 (es)
EP (1) EP2178535B1 (es)
JP (1) JP2010536860A (es)
KR (1) KR101227230B1 (es)
CN (1) CN101784275A (es)
AU (1) AU2008289347B2 (es)
BR (1) BRPI0815599A2 (es)
CA (1) CA2696613C (es)
ES (1) ES2392208T3 (es)
HK (1) HK1140700A1 (es)
MX (1) MX2010001841A (es)
TW (1) TW200918075A (es)
WO (1) WO2009026009A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102422068A (zh) 2009-03-11 2012-04-18 迪普弗莱克斯有限公司 用于修补挠性纤维增强管子的方法和设备
WO2018144909A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses
JP7289538B2 (ja) 2018-03-12 2023-06-12 国立大学法人高知大学 新規バクテリオファージおよび細菌性眼内炎治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
AU2002247284A1 (en) * 2001-04-02 2002-10-15 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
EP2136812B1 (en) * 2007-03-21 2013-09-04 Bausch & Lomb Incorporated Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria

Also Published As

Publication number Publication date
CA2696613C (en) 2012-09-18
KR20100034049A (ko) 2010-03-31
JP2010536860A (ja) 2010-12-02
KR101227230B1 (ko) 2013-01-28
US20090054406A1 (en) 2009-02-26
HK1140700A1 (en) 2010-10-22
WO2009026009A1 (en) 2009-02-26
ES2392208T3 (es) 2012-12-05
EP2178535B1 (en) 2012-09-19
AU2008289347B2 (en) 2011-12-08
AU2008289347A1 (en) 2009-02-26
TW200918075A (en) 2009-05-01
BRPI0815599A2 (pt) 2015-03-03
CA2696613A1 (en) 2009-02-26
EP2178535A1 (en) 2010-04-28
CN101784275A (zh) 2010-07-21

Similar Documents

Publication Publication Date Title
GB201106750D0 (en) Novel compounds
SG194469A1 (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
PH12015501661A1 (en) Pyridone amides as modulators of sodium channels
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
PH12014500053A1 (en) Proteasome inhibitors
MX2012000396A (es) Metodos y composiciones para uso en tartamientos celulares.
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
MX366130B (es) Inhibidores bivalentes de las proteinas iap y métodos terapéuticos que usan los mismos.
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
MX2015005963A (es) Inhibidores heterociclicos de glutaminasa.
TN2010000236A1 (en) Fused pyridine pyrimidine and triazine compounds as cell cycle inhibitors
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
MY162146A (en) Pharmaceutical composition
MX2014008706A (es) Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
MX370792B (es) Composiciones para usarse en el tratamiento de cáncer.
MX2010003009A (es) Piridil sulfonamidas como moduladores de canales ionicos.
EA201290789A1 (ru) Термогелеобразующие композиции анестетиков
MY191932A (en) Chitosan-derived compositions
UA114417C2 (uk) Інгібітори iap
PH12016500136A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
SA519401424B1 (ar) Cmet عوامل ربط أحادية النسيلة، مترافقات عقار منها واستخداماتها
MX368635B (es) Compuestos tricíclicos de piperidina.

Legal Events

Date Code Title Description
FG Grant or registration